-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

PUBT·07/17/2026 09:44:12
Listen to the news
Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation
  • Ascletis filed a next-day disclosure return showing a 300,000-share buyback for cancellation on July 17.
  • Repurchase range HKD 8.19 to HKD 9.63; aggregate cost HKD 2.58 million.
  • Issued shares unchanged at 1,061,370,845; treasury shares unchanged at 7,084,210.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248077), on July 17, 2026, and is solely responsible for the information contained therein.